๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT ยท Real-Time Price ยท USD
0.2522
+0.0393 (18.46%)
Nov 20, 2026, 9:55 AM EST - Market open

LABT Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Income
-6.9-3.77-4.03-8.64
Net Income
-8.04-5.85-6.86-8.28
Earnings Per Share
-6.16-8.40-9.92-12.16
EPS Growth
----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
3.320.240.686.39
Total Debt
0.071.660.270.58
Net Cash (Debt)
3.25-1.420.415.81
Net Cash Growth
---92.97%-
Net Cash Per Share
2.49-2.050.598.53

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-4.14-1.94-5.72-6.82
Capital Expenditures
---0-
Free Cash Flow
-4.14-1.94-5.73-6.82
Free Cash Flow Growth
----